| NIAGEN BIOSCIENCE |
| USA |
| Gesundheit |
| US1710774076 / A2AG5N |
| OCD1 (Frankfurt) / NAGE (NASDAQ) |
| FRA:OCD1, ETR:OCD1, OCD1:GR, NASDAQ:NAGE |
| - |
| https://www.niagenbioscie.. |
|
Niagen Bioscience Inc. is a bioscience company headquartered in Los Angeles, California. The company specializes in advancing NAD+ science to support cellular health and healthy aging through its proprietary Niagen platform, a patented NAD+-boosting ..
>Volltext.. |
| 313.57 Mio. EUR |
| 260.84 Mio. EUR |
| 112.12 Mio. EUR |
| 13.64 Mio. EUR |
| 15.06 Mio. EUR |
| 0.19 EUR |
| 2.44 Mio. EUR |
| 56.13 Mio. EUR |
| 11.64 Mio. EUR |
| 3.25 |
| 14.54% |
| 79.19% |
| - |
| - |
| - |
| - |
| NIAGEN BIOSCIENCE, NIAGEN BIO, CHROMADEX |
| 05.04.26 |
|